灵芝三萜与灵芝多糖抗肿瘤作用及其机制研究进展

王梦晨; 张雪涟; 陈向东; 兰进; 魏菲; 罗云; 孙晓波

doi:10.13422/j.cnki.syfjx.20220431

您当前的位置：

首页 >

文章列表页 >

灵芝三萜与灵芝多糖抗肿瘤作用及其机制研究进展

综述 | 更新时间：2022-02-07

- 灵芝三萜与灵芝多糖抗肿瘤作用及其机制研究进展
- Anti-tumor Effect and Mechanisms of Triterpenoids and Polysaccharides in Ganoderma lucidum： A Review
- 中国实验方剂学杂志 2022年28卷第5期页码：234-241
- 作者机构：
  
  中国医学科学院药用植物研究所，北京 100193
- 作者简介：
  
  王梦晨，硕士，从事中药药理学研究，E-mail：mengchenwang98@163.com
  罗云，博士，副研究员，从事中药药理学研究，E-mail：ly20040423@126.com； *
  孙晓波，博士，研究员，从事中药药理学研究，E-mail：sun_xiaobo163@163.com
- 基金信息：
  
  国家重点研发计划项目(2019YFC1710504)
- DOI：10.13422/j.cnki.syfjx.20220431
  中图分类号： R22;R242;R2-031;R285.5
- 纸质出版日期：2022-03-05，
  
  网络出版日期：2021-12-13，
  
  收稿日期：2021-10-05，
- 稿件说明：
扫描看全文
王梦晨,张雪涟,陈向东等.灵芝三萜与灵芝多糖抗肿瘤作用及其机制研究进展[J].中国实验方剂学杂志,2022,28(05):234-241.

WANG Meng-chen,ZHANG Xue-lian,CHEN Xiang-dong,et al.Anti-tumor Effect and Mechanisms of Triterpenoids and Polysaccharides in Ganoderma lucidum： A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(05):234-241.
王梦晨,张雪涟,陈向东等.灵芝三萜与灵芝多糖抗肿瘤作用及其机制研究进展[J].中国实验方剂学杂志,2022,28(05):234-241. DOI： 10.13422/j.cnki.syfjx.20220431.

WANG Meng-chen,ZHANG Xue-lian,CHEN Xiang-dong,et al.Anti-tumor Effect and Mechanisms of Triterpenoids and Polysaccharides in Ganoderma lucidum： A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(05):234-241. DOI： 10.13422/j.cnki.syfjx.20220431.

摘要

随着人口老龄化程度的加剧，肿瘤患者的发病率和死亡率持续上升。目前肿瘤的治疗方法包括手术、化疗、放疗、靶向治疗、免疫治疗，然而大部分化疗药物可引起严重的副作用和耐药性。因此中医药治疗作为一种替代疗法可以有效地改善肿瘤患者的临床症状，提高生活质量，抑制或稳定肿瘤的发展，延长患者生存期限。由于中药具有良好的安全性，其抗癌潜力日益受到关注。灵芝是一种药用真菌，在我国有着两千多年的历史，是我国中草药宝库中的一个珍品。迄今为止，有许多研究已经提出了灵芝的抗癌特性。灵芝具有广泛的药理作用，如抗肿瘤、调节免疫、保肝、降血糖血脂、抗动脉粥样硬化、保护心脏、抗衰老等。灵芝的化学成分较为复杂，目前已知含有多糖、三萜类、生物碱、核苷类、氨基酸及各种微量元素，灵芝多糖和三萜类化合物的抗肿瘤机制主要通过诱导细胞凋亡、免疫调节、抗血管生成、阻滞细胞周期等来实现。已广泛应用于肺癌、肝癌、宫颈癌、前列腺癌、乳腺癌、结肠癌等多种肿瘤的辅助治疗。该文通过对近年来灵芝三萜和灵芝多糖的生物活性及作用机制的相关文献进行归纳汇总，重点综述其抗肿瘤作用及作用机制，以期为灵芝抗肿瘤的进一步开发利用提供参考和借鉴。

Abstract

With the population aging， the morbidity and mortality of cancer patients continue to rise. At present， the treatment methods for tumors include surgery， chemotherapy， radiotherapy， targeted therapy， and immunotherapy. However， most chemotherapeutic drugs can cause severe side effects and drug resistance. Therefore， as an alternative therapy， traditional Chinese medicine （TCM） treatment can effectively relieve the clinical symptoms of tumor patients， improve the quality of life， inhibit or stabilize the development of tumors， and prolong the survival period of patients. Due to the good safety of Chinese medicine， its potential anti-cancer activity has attracted increasing attention.

Ganoderma lucidum，

a treasure of Chinese medicinal material， is a medicinal fungus with a history of more than 2 000 years in China. So far， many studies have proposed the anti-cancer properties of

G. lucidum

has extensive pharmacological activities， such as anti-tumor， anti-atherosclerosis， and anti-aging. It can also regulate immunity， protect the liver and the heart， and reduce blood glucose and lipid. The chemical composition of

G. lucidum

is complex. At present， it is proved to contain polysaccharides， triterpenoids， alkaloids， nucleosides， amino acids， and various trace elements. The anti-tumor mechanisms of

polysaccharides and triterpenoids in

G. lucidum

are mainly achieved by apoptosis induction， immune regulation， anti-angiogenesis， and induction of cell cycle arrest. Currently， it has been widely used in the adjuvant treatment of complex tumors such as lung cancer， liver cancer， cervical cancer， prostate cancer， breast cancer， and colon cancer. The present study reviewed the bioactivities and mechanisms of triterpenoids and polysaccharides in

G. lucidum

in recent years and highlighted the anti-tumor effects and mechanisms to provide references for the further development and utilization of

G. lucidum

关键词

灵芝三萜灵芝多糖抗肿瘤作用机制

Keywords

Ganoderma lucidum triterpenoidsGanoderma lucidum polysaccharidesanti-tumor effectmechanism

references

BARBIERI A， QUAGLIARIELLO V， DEL VECCHIO V ， et al. Anticancer and anti-inflammatory properties of ganoderma lucidum extract effects on melanoma and triple-negative breast cancer treatment ［J］. Nutrients， 2017， doi： 10.3390/nu9030210http://dx.doi.org/10.3390/nu9030210.

KAO C， JESUTHASAN A C， BISHOP K S， et al. Anti-cancer activities of Ganoderma lucidum： active ingredients and pathways ［J］. Funct Food Health Dis， 2013， 3（2）： 48-65.

SHIAO M S. Natural products of the medicinal fungus Ganoderma lucidum： occurrence， biological activities， and pharmacological functions ［J］. Chem Rec， 2003， 3（3）： 172-180.

LIN Z B. Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum ［J］. J Pharmacol Sci， 2005， 99（2）： 144-153.

ZHAO C， FAN J， LIU Y， et al. Hepatoprotective activity of Ganoderma lucidum triterpenoids in alcohol-induced liver injury in mice， an iTRAQ-based proteomic analysis ［J］. Food Chem， 2019， doi： 10.1016/j.foodchem.2018.07.115http://dx.doi.org/10.1016/j.foodchem.2018.07.115.

PAN D， ZHANG D， WU J， et al. Antidiabetic， antihyperlipidemic and antioxidant activities of a novel proteoglycan from ganoderma lucidum fruiting bodies on db/db mice and the possible mechanism ［J］. PLoS One， 2013， doi： 10.1371/journal.pone.0068332http://dx.doi.org/10.1371/journal.pone.0068332.

WANG J， CAO B， ZHAO H， et al. Emerging roles of Ganoderma lucidum in anti-aging ［J］. Aging Dis， 2017， 8（6）： 691-707.

HU Z， DU R， XIU L， et al. Protective effect of triterpenes of Ganoderma lucidum on lipopolysaccharide-induced inflammatory responses and acute liver injury ［J］. Cytokine， 2020， doi： 10.1016/j.cyto.2019.154917http://dx.doi.org/10.1016/j.cyto.2019.154917.

GENG P， SIU K C， WANG Z， et al. Antifatigue functions and mechanisms of edible and medicinal mushrooms ［J］. Biomed Res Int， 2017， doi： 10.1155/2017/9648496http://dx.doi.org/10.1155/2017/9648496.

KOZARSKI M， KLAUS A， JAKOVLJEVIC D， et al. Ganoderma lucidum as a cosmeceutical： antiradical potential and inhibitory effect on hyperpigmentation and skin extracellular matrix degradation enzymes ［J］. Arch Biol Sci， 2019， 71（2）： 253-264.

LASUKOVA T V， MASLOV L N， ARBUZOV A G， et al. Cardioprotective activity of Ganoderma lucidum extract during total ischemia and reperfusion of isolated heart ［J］. Bull Exp Biol Med， 2015， 158（6）： 739-741.

FUJITA R， LIU J， SHIMIZU K， et al. Anti-androgenic activities of Ganoderma lucidum ［J］. J Ethnopharmacol， 2005， 102（1）： 107-112.

ZENG P， CHEN Y， ZHANG L， et al. Ganoderma lucidum polysaccharide used for treating physical frailty in China ［J］. Prog Mol Biol Transl Sci， 2019， doi： 10.1016/bs.pmbts.2019.02.009http://dx.doi.org/10.1016/bs.pmbts.2019.02.009.

LI Y， TANG J， GAO H， et al. Ganoderma lucidum triterpenoids and polysaccharides attenuate atherosclerotic plaque in high-fat diet rabbits ［J］. Nutr Metab Cardiovasc Dis， 2021， 31（6）： 1929-1938.

OH K K，ADNAN M，CHO D H.A network pharmacology analysis on drug-like compounds from Ganoderma lucidum for alleviation of atherosclerosis［J］.J Food Biochem，2021，45（9）：e13906.

马传贵，张志秀，佟富军.灵芝对心脑血管保护作用的机制及其研究进展［J］.医学食疗与健康，2021，19（5）：191-192，205.

HUIE C W， DI X. Chromatographic and electrophoretic methods for Lingzhi pharmacologically active components ［J］. J Chromatogr B Analyt Technol Biomed Life Sci， 2004， 812（1）： 241-257.

李亚晗，刘佳琳，王天添，等.灵芝多糖抗肿瘤免疫调节机制的研究进展［J］.中国免疫学杂志，2021，37（4）：511-512.

ZOLJ S， SMITH M P， GOINES J C， et al. Antiproliferative effects of a triterpene-enriched extract from lingzhi or reishi medicinal mushroom， ganoderma lucidum （agaricomycetes）， on human lung cancer cells ［J］. Int J Med Mushrooms， 2018， 20（12）： 1173-1183.

LIU W， YUAN R， HOU A， et al. Ganoderma triterpenoids attenuate tumour angiogenesis in lung cancer tumour-bearing nude mice ［J］. Pharm Biol， 2020， 58（1）： 1061-1068.

WANG W， GOU X， XUE H， et al. Ganoderan （GDN） regulates the growth， motility and apoptosis of non-small cell lung cancer cells through ERK signaling pathway in vitro and in vivo［J］. Onco Targets Ther， 2019， doi： 10.2147/OTT.S221161http://dx.doi.org/10.2147/OTT.S221161.

GUO J， YUAN C， HUANG M， et al. Ganoderma lucidum-derived polysaccharide enhances coix oil-based microemulsion on stability and lung cancer-targeted therapy ［J］. Drug Deliv， 2018， 25（1）： 1802-1810.

李志强，何玉霞. 灵芝多糖对人肺癌A549细胞增殖凋亡的作用［J］. 现代食品科技， 2021， 37（5）： 38-42.

HSU W H， QIU W L， TSAO S M， et al. Effects of WSG， a polysaccharide from Ganoderma lucidum， on suppressing cell growth and mobility of lung cancer ［J］. Int J Biol Macromol， 2020， 165（Pt A）： 1604-1613.

ZHU J，XU J，JIANG L L，et al.Improved antitumor activity of cisplatin combined with Ganoderma lucidum polysaccharides in U14 cervical carcinoma-bearing mice［J］.Kaohsiung J Med Sci，2019，35（4）：222-229.

WANG C Z， BASILA D， AUNG H H， et al. Effects of ganoderma lucidum extract on chemotherapy-induced nausea and vomiting in a rat model ［J］. Am J Chin Med， 2005， 33（5）： 807-815.

SUN L X， LI W D， LIN Z B， et al. Protection against lung cancer patient plasma-induced lymphocyte suppression by Ganoderma lucidum polysaccharides ［J］. Cell Physiol Biochem， 2014， 33（2）： 289-299.

RUAN W，WEI Y，POPOVICH D G.Distinct Responses of cytotoxic ganoderma lucidum triterpenoids in human carcinoma cells［J］.Phytother Res，2015，29（11）：1744-1752.

LIU D L，LI Y J，YANG D H，et al.Ganoderma lucidum derived ganoderenic acid B reverses ABCB1-mediated multidrug resistance in HepG2/ADM cells［J］.Int J Oncol，2015，46（5）：2029-2038.

LI A， SHUAI X， JIA Z， et al. Ganoderma lucidum polysaccharide extract inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulation and function by inducing microRNA-125b ［J］. J Transl Med， 2015， doi： 10.1186/s12967-015-0465-5http://dx.doi.org/10.1186/s12967-015-0465-5.

NESTAL D E， MORAES G，BELLA L，et al.Insights into a critical role of the FOXO3a-FOXM1 axis in dna damage response and genotoxic drug resistance［J］.Curr Drug Targets，2016，17（2）：164-177.

TANG C， ZHAO R， NI H， et al. Molecule mechanisms of Ganoderma lucidum treated hepatocellular carcinoma based on the transcriptional profiles and miRNA-target network ［J］. Biomed Pharmacother， 2020， doi： 10.1016/j.biopha.2020.110028http://dx.doi.org/10.1016/j.biopha.2020.110028.

YU Y， QIAN L， DU N， et al. Ganoderma lucidum polysaccharide enhances radiosensitivity of hepatocellular carcinoma cell line HepG2 through Akt signaling pathway ［J］. Exp Ther Med， 2017， 14（6）： 5903-5907.

LIU R M， LI Y B， LIANG X F， et al. Structurally related ganoderic acids induce apoptosis in human cervical cancer HeLa cells： Involvement of oxidative stress and antioxidant protective system ［J］. Chem Biol Interact， 2015， doi： 10.1016/j.cbi.2015.08.005http://dx.doi.org/10.1016/j.cbi.2015.08.005.

YUE Q X，SONG X Y，MA C，et al.Effects of triterpenes from Ganoderma lucidum on protein expression profile of HeLa cells［J］.Phytomedicine，2010，17（8/9）：606-613.

KONG M， YAO Y， ZHANG H. Antitumor activity of enzymatically hydrolyzed Ganoderma lucidum polysaccharide on U14 cervical carcinoma-bearing mice ［J］. Int J Immunopathol Pharmacol， 2019， doi： 10.1177/2058738419869489http://dx.doi.org/10.1177/2058738419869489.

JIN H， SONG C， ZHAO Z， et al. Ganoderma lucidum polysaccharide， an extract from ganoderma lucidum， exerts suppressive effect on cervical cancer cell malignancy through mitigating epithelial-mesenchymal and JAK/STAT5 signaling pathway ［J］. Pharmacology， 2020， 105（7/8）： 461-470.

王涛. 灵芝三萜的提纯及其对前列腺癌细胞生长的影响［D］. 广州：南方医科大学，2016.

ZHAO X， ZHOU D， LIU Y， et al. Ganoderma lucidum polysaccharide inhibits prostate cancer cell migration via the protein arginine methyltransferase 6 signaling pathway ［J］. Mol Med Rep， 2018， 17（1）： 147-157.

QU L， LI S， ZHUO Y， et al. Anticancer effect of triterpenes from Ganoderma lucidum in human prostate cancer cells ［J］. Oncol Lett， 2017， 14（6）： 7467-7472.

WU K K， NA K， CHEN D， et al. Effects of non-steroidal anti-inflammatory drug-activated gene-1 on Ganoderma lucidum polysaccharides-induced apoptosis of human prostate cancer PC-3 cells ［J］. Int J Oncol， 2018， 53（6）： 2356-2368.

GILL B S， NAVGEE T，KUMAR S. Ganoderma lucidum targeting lung cancer signaling： A review［J］. Tumour Biol， 2017， doi： 10.1177/1010428317707437http://dx.doi.org/10.1177/1010428317707437.

SUÁREZ-ARROYO I J， LOPERENA-ALVAREZ Y， ROSARIO-ACEVEDO R， et al. Ganoderma spp.： a promising adjuvant treatment for breast cancer ［J］. Medicines （Basel）， 2017， doi： 10.3390/medicines4010015http://dx.doi.org/10.3390/medicines4010015.

ZHANG Y. Ganoderma lucidum （Reishi） suppresses proliferation and migration of breast cancer cells via inhibiting Wnt/β-catenin signaling ［J］. Biochem Biophys Res Commun， 2017，488（4）： 679-684.

SMINA T P， NITHA B， DEVASAGAYAM T P， et al. Ganoderma lucidum total triterpenes induce apoptosis in MCF-7 cells and attenuate DMBA induced mammary and skin carcinomas in experimental animals ［J］. Mutat Res Genet Toxicol Environ Mutagen， 2017， doi： 10.1016/j.mrgentox.2016.11.010http://dx.doi.org/10.1016/j.mrgentox.2016.11.010.

SU J， LI D， CHEN Q， et al. Anti-breast cancer enhancement of a polysaccharide from spore of Ganoderma lucidum with paclitaxel： suppression on tumor metabolism with gut microbiota reshaping ［J］. Front Microbiol， 2018， doi： 10.3389/fmicb.2018.03099http://dx.doi.org/10.3389/fmicb.2018.03099.

LI P， LIU L， HUANG S， et al. Anti-cancer effects of a neutral triterpene fraction from Ganoderma lucidum and its active constituents on SW620 human colorectal cancer cells ［J］. Anticancer Agents Med Chem， 2020， 20（2）： 237-244.

BAI J H， XU J， ZHAO J， et al. Ganoderma lucidum polysaccharide enzymatic hydrolysate suppresses the growth of human colon cancer cells via inducing apoptosis ［J］. Cell Transplant， 2020， doi： 10.1177/0963689720931435http://dx.doi.org/10.1177/0963689720931435.

THYAGARAJAN A， JEDINAK A， NGUYEN H， et al. Triterpenes from ganoderma lucidum induce autophagy in colon cancer through the inhibition of p38 mitogen-activated kinase （p38 MAPK）［J］. Nutr Cancer， 2010， 62（5）： 630-640.

SHAO C S， ZHOU X H， ZHENG X X， et al. Ganoderic acid D induces synergistic autophagic cell death except for apoptosis in ESCC cells ［J］. J Ethnopharmacol， 2020， doi： 10.1016/j.jep.2020.113213http://dx.doi.org/10.1016/j.jep.2020.113213.

BHARADWAJ S， LEE K E， DWIVEDI V D， et al. Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease ［J］. Sci Rep， 2019， doi： 10.1038/s41598-019-55723-5http://dx.doi.org/10.1038/s41598-019-55723-5.

ZHU Q C， BANG T H， OHNUKI K， et al. Inhibition of neuraminidase by Ganoderma triterpenoids and implications for neuraminidase inhibitor design ［J］. Sci Rep， 2015， doi： 10.1038/srep13194http://dx.doi.org/10.1038/srep13194.

EL-MEKKAWY S， MESELHY M R， NAKAMURA N， et al. Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum ［J］. Phytochemistry， 1998， 49（6）： 1651-1657.

EO S K， KIM Y S， LEE C K， et al. Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum ［J］. J Ethnopharmacol， 1999， 68（1-3）： 129-136.

ZHONG J， FANG L， CHEN R， et al. Polysaccharides from sporoderm-removed spores of Ganoderma lucidum induce apoptosis in human gastric cancer cells via disruption of autophagic flux ［J］. Oncol Lett， 2021， 21（5）： 425.

CHEN M， XIAO D， LIU W， et al. Intake of Ganoderma lucidum polysaccharides reverses the disturbed gut microbiota and metabolism in type 2 diabetic rats ［J］. Int J Biol Macromol， 2020， doi： 10.1016/j.ijbiomac.2019.11.047http://dx.doi.org/10.1016/j.ijbiomac.2019.11.047.

CHERIAN E， SUDHEESH N P， JANARDHANAN K K， et al. Free radical scavenging and mitochondrial antioxidant activities of Reishi-Ganoderma lucidum （Curt： Fr） P. Karst and arogyapacha-trichopus zeylanicus gaertn extracts ［J］. J Basic Clin Physiol Pharmacol， 2009， 20（4）： 289-307.

CHEN S， XU J， LIU C， et al. Genome sequence of the model medicinal mushroom Ganoderma lucidum ［J］. Nat Commun， 2012， doi： 10.1038/ncomms1923http://dx.doi.org/10.1038/ncomms1923.

STÅHL P L， SALMÉN F， VICKOVIC S， et al. Visualization and analysis of gene expression in tissue sections by spatial transcriptomics ［J］. Science， 2016， 353（6294）： 78-82.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

运脾化浊方对Wilson病铜稳态影响及机制

葛根芩连汤及其加减方改善2型糖尿病胰岛素抵抗作用研究进展

MAPK信号通路在防治类风湿关节炎中的作用及中药干预研究进展

桑叶降糖有效部位提取工艺及作用机制研究进展

特发性肺纤维化的发病机制及中药调节作用研究进展